Rare diseases
Investigational molecules
Locations
Back to France8 clinical trials in Antibes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Methotrexate Treatment for Patients with Erosive Hand Osteoarthritis Not Responding to Standard Therapy
FranceStudy on Dapagliflozin for Heart and Kidney Health in Adults After ICU Discharge with Heart or Kidney Issues
FranceStudy on the Impact of Cefepime, Piperacillin-Tazobactam, and Ceftobiprole on Gut Health in Patients with Bone and Joint Infections on Implants
FranceStudy Comparing Sodium Chloride and Sodium Lactate for Treating Severe Diabetic Ketoacidosis in ICU Patients
FranceStudy on the Safety and Effectiveness of IPN10200 and Botulinum Toxin Type A for Adults with Moderate to Severe Upper Facial Lines
FranceFranceStudy on BP1.7881 for Adults with Eosinophilic Esophagitis
FranceStudy on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on diabetic ketoacidosis management in intensive care settings, exploring optimal fluid resuscitation methods and investigating cardio-renal protection strategies for ICU patients.
Studies aim to enhance treatment protocols and improve patient outcomes in critical care scenarios.
Clinical investigations examining innovative treatments for facial aesthetics, including studies on upper facial lines and masseter muscle prominence reduction.
Research focuses on developing safe and effective aesthetic solutions with measurable outcomes.
Comprehensive studies addressing both acute myocardial infarction and digestive disorders, including innovative treatments for eosinophilic esophagitis.
These trials aim to advance treatment strategies and improve patient care standards.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
